Alessandra L.
- Country
- Italy
- Department
- 380001: SSD Clinical Trial in Oncoematologia e Mieloma Multiplo
Research Overview
- International, multi-center, open-label, treatment extension study in patients with multiple myeloma who are still benefitting from isatuximab-based therapy following completion of a Phase 1, 2, or 3 parental study
- Phase 3 Randomized Trial of Teclistamab and Talquetamab Combinations Versus Standard Regimen in Newly Diagnosed Multiple Myeloma Ineligible for Transplant
- Phase III Randomized Trial of Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Ineligible for ASCT
Data & Insights
Has run more than one trial at 74 of 218 partner sites.
Specializations
Multiple Myeloma Treatment
The investigator specializes in treating newly diagnosed multiple myeloma, particularly focusing on therapeutic approaches for patients who are ineligible for autologous stem cell transplantation.
- Age-specific Treatment Strategies
- Transplant-ineligible Patient Care
- Novel Therapeutic Combinations
Their research encompasses innovative treatment combinations including daratumumab-based therapies and immunomodulatory approaches.
Therapeutic Innovation
The investigator explores advanced treatment protocols involving targeted antibody therapies and novel drug combinations for hematologic malignancies.
- Combination Therapy Development
- Treatment Response Assessment
- Real-world Clinical Outcomes
Their work includes evaluating progression-free survival in various therapeutic regimens.
Specialized Patient Care
The investigator focuses on developing treatment strategies for elderly patients with multiple myeloma, particularly those aged 65 and above.
- Elderly Patient Management
- Alternative Treatment Approaches
- Quality of Life Considerations
Their research emphasizes optimizing treatment outcomes for patients unsuitable for intensive therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.